Micron Tops $1 Trillion in Value as UBS Says Stock Could Double Bloomberg.com Micron closes in on $1 trillion market value as UBS triples share price target Reuters Micron Investors Are Partying Like It's 1987, and the Stock Still Looks Pretty Cheap Moomoo

Micron Technology, Inc. (MU) Stock Price, News, Quote & History Yahoo Finance

TATE 1997 Trust reports multiple May 2026 stock sales for ALAB (ALAB) Stock Titan

Modine Manufacturing press release ( MOD ): Q4 Non-GAAP EPS of $1.71 beats by $0.16 . Revenue of $954.4M (+39.8% Y/Y) beats by $33.72M . Full-Year Highlights: Record net sales of $3.2 billion increased $597.6 million, or 23 percent, from the prior year Net earnings of $123.3 million decreased $62.2 million, or 34 percent, from the prior year and included a $116.1 million non-cash pension termination charge in the third quarter Earnings per share of $2.26 decreased $1.16, or 34 percent, from the prior year Record adjusted EBITDA of $471.0 million increased $78.9 million, or 20 percent, from the prior year Record adjusted earnings per share of $5.02 increased $0.97, or 24 percent, from the prior year Fiscal 2027 Outlook: Net sales growth between 20 percent and 35 percent Adjusted EBITDA range of $650 million to $680 million, resulting in growth between 38 percent and 44 percent Shares -2.3% AH. More on Modine Manufacturing Modine: This Powerhouse Stock Can Keep Going The Coiled Spring Effect: Why Modine's Gross Profit Signals Explosive Stock Upside Modine: Breakout Frenzy Meets AI Beneficiary Status - Downgrade To Hold Modine Manufacturing soars to a new all-time high after inking a new deal to cool data centers Modine Manufacturing Q4 2026 Earnings Preview

Medifast ( MED ) has appointed Nicholas Johnson as chief executive officer, effective June 1, 2026. Johnson will succeed Dan Chard as CEO, who will continue to serve as chairman of the board. Source: Press Release More on Medifast Why Medifast's $15 Cash Per Share Makes It A Strong Buy Medifast: Worth Putting On A Watchlist Why is Medifast stock surging despite weak Q1? $30M cost-cut plan Medifast reconfirms $270M-$300M 2026 revenue outlook as it targets profitability improvements starting in Q4 2026

In trading on Thursday, shares of Brookfield Renewable Corp (Symbol: BEPC) crossed above their 200 day moving average of $26.28, changing hands as high as $26.72 per share. Brookfield Renewable Corp shares are currently trading up about 2.8% on the day. The chart below shows the one year performance of BEPC shares, versus its 200 day moving average: Looking at the chart above, BEPC's low point in its 52 week range is $21.35 per share, with $36.16 as the 52 week high point — that compares with a last trade of $26.53. Click here to find out which 9 other energy stocks recently crossed above their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In trading on Tuesday, shares of Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) were yielding above the 7.5% mark based on its quarterly dividend (annualized to $1.4688), with shares changing hands as low as $19.51 on the day. This compares to an average yield of 8.10% in the "Banking & Savings" preferred stock category, according to Preferred Stock Channel . As of last close, BWBBP was trading at a 21.00% discount to its liquidation preference amount, versus the average discount of 2.63% in the "Banking & Savings" category. Investors should keep in mind that the shares are not, meaning that in the event of a missed payment, the company does not have to pay the balance of missed dividends to preferred shareholders before resuming a common dividend. The chart below shows the one year performance of BWBBP shares, versus BWB: Below is a dividend history chart for BWBBP, showing historical dividend payments on Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A: In Tuesday trading, Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) is currently off about 0.1% on the day, while the common shares (Symbol: BWB) are up about 1.1%. Further BWBBP Research: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

美股三大股指收盘涨跌不一。道琼斯指数跌0.23%，标普500指数涨0.61%，纳斯达克综合指数涨1.19%。存储芯片板块领涨，美光科技大涨超19%，总市值首次突破1万亿美元；闪迪涨超7%，西部数据涨超8%，希捷科技涨4%。纳斯达克中国金龙指数收涨0.57%。网易涨近6%，小马智行涨近5%，哔哩哔哩涨超3%，京东跌近2%。

Palantir vs. BigBear.ai: Which AI Stock Is the Better Buy in 2026? The Motley Fool

格隆汇5月27日｜美国贸易代表格里尔在外交关系委员会的活动中表示，301调查的任何拟议措施都将征求公众意见。

In this article GLD GDX NEM Follow your favorite stocks CREATE FREE ACCOUNT watch now VIDEO 1:27 01:27 Options Action: Big moves in gold Halftime Report Has gold lost its luster? Traders on both sides of the question are duking it out in the options pit of one ETF that's trying to buck the multi-month downtrend in the commodity. Options volumes leaned bullish in both the SPDR Gold ETF (GLD) and VanEck Gold Miners ETF (GDX) on Tuesday as GDX posted a more than 4% rally despite gold futures dropping on the session. Bullish flows were particularly strong in GDX, with call volumes outpacing puts more than 5 to 1 at one point of the trading day. In GDX, more than 10,000 calls traded at the ask or above, meaning they were likely bought, compared to 4,400 puts bought, according to data from ThinkOrSwim. The most popular contracts by volume were the 100 and 110-strike calls expiring June 18, according to SpotGamma. Those calls need big double-digit rallies from here to break even. A separate, much bigger trader in the same GDX market doesn't think that will happen. The biggest premium trade of the day was someone spending more than $1 million – more than the combined premium of both the 100 and 110 calls – scooping up thousands of the 85-strike puts expiring July 17. The opposing trades offer a perspective on what could be a make-or-break moment for the precious metal as geopolitics remain unpredictable and the interest-rate outlook gets muddied as well. Gold's down almost 20% from its all-time high in January but still up 89% the past two years. Gold miners, by comparison, are up 144% over the same time period. Stock Chart Icon Stock chart icon Gold futures, 1 year Traders looking for another clue might find one in options trading around gold miner Newmont Mining , with activity on Tuesday nearing 100,000 contracts and almost $500M of options premium, according to Spotgamma. The trading skewed notably bearish, with millions of call sales including one of the biggest trades...

Enhanced Group Inc. shares fell to an all-time low after its inaugural sports-entertainment event was marred by technical problems and questions over its only world-record performance, disappointing investors weeks after its public listing. Shares dropped 43% to $ 3.03 in New York on Tuesday, closing at its lowest level on record. Enhanced Group went public May 8 through a merger with blank-check company A Paradise Acquisition Corp. The Enhanced Games, which allow athletes to use performance-enhancing drugs, took place Sunday in Las Vegas after drawing controversy ahead of the event. A livestream froze for more than 10 minutes during the first competition, Yahoo Sports reported Monday. The event produced one world-record performance, though The Guardian reported concerns over how it was timed. Enhanced Group dismissed the claims as “internet drivel.” Three athletes described by organizers as clean — Fred Kerley, Tristan Evelyn and Hunter Armstrong — won their events. Kerley’s time would have placed him last at the 2024 Paris Olympics, ESPN reported . Enhanced Group said after the event that it had surpassed $32 million in sponsorship value for the inaugural Games and had seven months remaining in the year to pursue additional sponsorships before a second event. The company didn’t respond to requests for comment.

Following the latest round of quarterly earnings releases, quant ratings provide a fresh snapshot of where small-cap financial stocks stand across important investment metrics. The companies below, with market capitalizations above $10B, represent the highest- and lowest-rated financial names after recent earnings announcements. The scoring framework reflects performance across valuation, growth, profitability, momentum, and earnings estimate changes. Top-quant rated stocks: Bank of America ( BAC ), Quant Rating: 4.92, Strong Buy. HSBC Holdings plc ( HSBC ), Quant Rating: 4.86, Strong Buy. Galaxy Digital ( GLXY ), Quant Rating: 4.83, Strong Buy. BB Seguridade Participações ( BBSEY ), Quant Rating: 4.83, Strong Buy. Standard Chartered ( SCBFY ), Quant Rating: 4.82, Strong Buy. Bottom-quant-rated stocks: Erie Indemnity ( ERIE ), Quant Rating: 1.26, Strong Sell. Houlihan Lokey ( HLI ), Quant Rating: 1.49, Strong Sell. Brown & Brown ( BRO ), Quant Rating: 1.75, Sell. The Carlyle Group ( CG ), Quant Rating: 1.78, Sell. Equitable Holdings ( EQH ), Quant Rating: 1.83, Sell. More on Bank of America, HSBC Holdings, etc. HSBC Holdings plc (HSBC) Analyst/Investor Day Prepared Remarks Transcript Standard Chartered PLC (SCBFY) Discusses Strategic Priorities, Growth Initiatives, and Medium-Term Financial Framework - Slideshow HSBC Holdings plc (HSBC) Analyst/Investor Day - Slideshow Galaxy Digital, BRC among financial stocks to join the Russell 3000; eHealth, SelectQuote to exit JP Morgan, Bank of America, and Citi 'living wills' cleared by Fed, FDIC

Appography/iStock via Getty Images Investment Overview In my last note on Lexicon Pharmaceuticals, Inc. ( LXRX ), shared with Seeking Alpha readers in mid-November last year, I assigned the Woodlands, Texas based Pharma a Buy rating, comparing the investment opportunity to "a lottery ticket with three chances to win." Buy has proven to be the right call so far, as today, Lexicon stock trades at $1.47 per share, up >40% since my note, and its market cap valuation is ~$917m (at the time of writing). I covered the company's history - from a $200m IPO in 2000 to a fall to <$0.5 per share last year after an FDA rejection (the second) for its candidate sotagliflozin, an inhibitor of sodium-glucose cotransporter types ("SGLT") 1 and 2, in the indication of Type 1 Diabetes ("T1D"), then a recovery driven by, among other things, the sales of ex-U.S. rights to sotagliflozin to global Pharma Viatris ( VTRS ), a partnership struck with Danish Pharma giant Novo Nordisk ( NVO ) to co-develop candidate LX9851, an orally bioavailable, investigational small molecule ACSL5 inhibitor, and progress with its pain medication pilavapadin. Lexicon stock is now up a remarkable ~230% on a 12-month basis and up >75% year-to-date, but with its share price still trading not far off delisting levels (Nasdaq listing laws require stock to consistently trade >$1 per share), this remains a higher-risk investment opportunity. As such, in this note, I'll update on the company's progress since last November, explain why I still consider Lexicon to be a "three-in-one" or even "four-in-one" opportunity, and advise if a change to my Buy rating is warranted. Lexicon: Catching Up On Recent Progress On May 7th, Lexicon announced its Q1 2026 earnings. The company earned $21m in revenues, $20m of which related to development milestone revenue from its license agreement with Novo Nordisk and $1.1m from net sales of Inpefa (sotagliflozin), which was approved for the indication of reduction of the risk of cardiov...

AGM Group Holdings ( NASDAQ: AGMH ) on Tuesday said it had received a notice from Nasdaq stating the company was not in compliance with listing rules after failing to timely file its annual report on Form 20-F for the year ended December 31, 2025. The company said the notice, dated May 18, relates to Nasdaq Listing Rule 5250(c)(1), which requires listed companies to file periodic financial reports with the U.S. Securities and Exchange Commission on time. AGM Group said the notice has no immediate effect on the listing or trading of its shares on Nasdaq. Under Nasdaq rules, the company has 60 calendar days from the date of the notice to submit a plan to regain compliance. If accepted, Nasdaq may grant an extension until November 11, 2026, for the company to file the delayed Form 20-F. The company said it is working to complete and file the report as soon as practicable. Source: Press Release More on AGM Group Financial information for AGM Group

It's been a challenging year for retailers. Inflation, geopolitical conflicts, and tariffs drove up costs, while the same macro headwinds curbed consumer demand for new products. However, not all retailers sank with the broader sector. Let's review the winners and losers from this earnings season, and where those stocks might head over the next year. The winner: Target Target's (TGT 0.14%) first-quarter earnings report impressed investors as its comparable sales finally grew again after a year-long slowdown. It expects net sales to grow 4% for the full year, compared with its prior outlook of 2% growth and its 2% decline in fiscal 2025 (which ended this February). Expand NYSE : TGT Target Today's Change ( -0.14 %) $ -0.17 Current Price $ 125.43 Key Data Points Market Cap $57B Day's Range $ 124.05 - $ 126.84 52wk Range $ 83.44 - $ 133.10 Volume 4.4M Avg Vol 5.9M Gross Margin 25.65 % Dividend Yield 3.63 % That recovery was driven by its new CEO's "Back to Basics" strategy of reorganizing its stores, stabilizing its inventory, and improving its employee training. It also expanded its food and beverage categories while selling more essential items to reduce its dependence on pricier discretionary items like home decor and electronics. It slashed prices to keep up with competitors, expanded its Target 360 program to lock in more shoppers, and secured additional exclusive brand partnerships to differentiate itself from other retailers. Wall Street now expects Target's revenue and EPS to grow 4% and 1%, respectively, this year. Its stock still looks cheap at 15 times this year's earnings, and it pays a forward yield of 3.6%. The loser: Kohl's Kohl's (KSS +1.76%) latest report for the fourth quarter of 2025 was much worse. Its comps fell 3.1% for the full year, and it expects another 0%-2% decline for 2026. Unlike Target, which is leveraging its scale to stay competitive, Kohl's is still struggling to stay afloat in the crowded retail market. Expand NYSE : KSS Kohl's Today'...

Operations too frequent. Try again later Page not found, please try again later.

Nasa announced on Tuesday ambitious plans for three uncrewed lunar missions this year to kickstart construction of a $20bn moon base, and said it had chosen the Amazon founder Jeff Bezos’s Blue Origin, ahead of Elon Musk’s SpaceX, to conduct the first. The revelation by Nasa’s administrator, Jared Isaacman, at a press conference in Washington DC marked the first detailed public explanation of how and when the moon base will be built. He said the three missions planned for 2026 would be followed by “more than a dozen” more in the coming years to test systems and equipment. He said the highly successful Artemis II mission last month that sent four astronauts around the moon for the first time since 1972 had been both a catalyst and incentive to advance the moon base plan. “People are looking up again, believing in big things again, and paying attention as America returns to the moon again, and this time to stay,” he said. He added, without mentioning any names, that the agency had been “having the tough conversations with those failing to meet expectations” since the Artemis splashdown on 10 April. “We are not jumping right into the glass dome moon base. We intend to take an iterative approach, sending a demand signal to industry for a lot of landers and rovers and tech demonstrations, and all the scientific payloads these missions can accommodate,” Isaacman said. “We are leveraging the Nasa playbook from the 1960s, figuring out what works and what doesn’t in this epic science of survival, because the moon base is as beautiful as it is hostile.” The headline announcement was the selection of Bezos’s Blue Origin company to conduct the first mission, as early as fall. It has been awarded $230.4m to support each of its first two moon base missions, Nasa said, but will largely fund the operation itself. “Moon Base One will be the first privately funded lunar lander mission in history,” Isaacman said. It will take Endurance, Blue Origin’s cryogenically propelled cargo land...

Stocks kicked off the week with a broad rally that was fueled by semiconductor companies. The S&P 500 rose 0.6%, hitting a new record. The Dow fell 118 points or 0.2%, while celebrating its 130th birthday today.

Semtech press release ( SMTC ): Q1 Non-GAAP EPS of $0.51 beats by $0.06 . Revenue of $291M (+15.9% Y/Y) beats by $7.47M . Second Quarter of Fiscal Year 2027 Outlook (in millions, except per share data) Net sales $ 328.0 +/- $5.0 Non-GAAP Financial Measures Adjusted gross margin* 54.0 % +/- 50 bps Total semiconductor products gross margin* 62.1 % +/- 50 bps Adjusted operating expenses, net* $ 105.2 +/- $2.0 Adjusted operating income* $ 71.9 +/- $2.3 Adjusted operating margin* 21.9 % +/- 40 bps Adjusted interest and other expense, net* $ 0.5 Adjusted normalized tax rate* 17 % Adjusted diluted earnings per share* $ 0.61 +/- $0.02 Adjusted EBITDA* $ 79.2 +/- $2.3 Adjusted EBITDA margin* 24.2 % +/- 40 bps Non-GAAP diluted share count* 97.7 Click to enlarge More on Semtech Semtech Q4: Strong Finish To The Year, Hold For The Next Year Or So Semtech Corporation 2026 Q4 - Results - Earnings Call Presentation Semtech Corporation (SMTC) Q4 2026 Earnings Call Transcript Semtech Q1 2027 Earnings Preview Semtech outlines over 50% data center revenue growth for FY 2027 amid data center, LoRa, and acquisition momentum